- Home
- ORIC vs XPEL Comparison
ORIC vs XPEL Comparison
Compare ORIC & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | XPEL |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ORIC | XPEL |
|---|---|---|
| Price | $9.11 | $42.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | $21.93 | ★ $61.67 |
| AVG Volume (30 Days) | ★ 1.3M | 140.1K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | 12.12 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $476,200,000.00 |
| Revenue This Year | N/A | $11.71 |
| Revenue Next Year | N/A | $10.64 |
| P/E Ratio | ★ N/A | $41.86 |
| Revenue Growth | N/A | ★ 13.27 |
| 52 Week Low | $7.23 | $31.88 |
| 52 Week High | $14.68 | $55.91 |
Technical Indicators
Market Signals| Indicator | ORIC | XPEL |
|---|---|---|
| Relative Strength Index (RSI) | 29.39 | 39.25 |
| Support Level | $7.40 | $42.57 |
| Resistance Level | $9.13 | $46.61 |
| Average True Range (ATR) | 1.05 | 1.28 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 1.79 | 1.33 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.